Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1352693

registered interest
date	03/09/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department plans to provide similar guidance to the temporary clinical authorisation granted by the Medicine and Healthcare Products Regulatory Agency (MHRA) to the Pfizer/BioNtech vaccine on 2 December 2020, to the MHRA in regards to the fast-tracking of nasal covid-19 vaccines; and if he will make a statement.
tabling member constituency	Broxbourne
tabling member printed	Sir Charles Walker
uin	41742
answer	answer is ministerial correction date of answer 08/09/2021 answer text <p>COVID-19 vaccines which can be administered nasally are currently in early clinical trials. Any route to approval of such treatments will be subject to the developer seeking regulatory approval from the United Kingdom’s independent medicines regulator, the Medicines and Healthcare products Regulatory Agency.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 08/09/2021 13:59:54 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1493 label Biography information for Sir Charles Walker

1349539

registered interest
date	22/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what guidance he has published on mixing covid-19 vaccine doses in people aged under 40; and if he will make a statement.
tabling member constituency	Broxbourne
tabling member printed	Sir Charles Walker
uin	38162
answer	answer is ministerial correction date of answer 06/09/2021 answer text <p>Mixing COVID-19 vaccines is not currently advised, unless in exceptional circumstances as there is currently limited evidence of effectiveness and the duration of protection. Guidance on when mixing COVID-19 vaccines may be appropriate has been published in the Green Book, which provides guidance for public health professionals on use of COVID-19 vaccines in the vaccine deployment programme. This advice is also reflected in the guidance on the vaccination programme for healthcare practitioners.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 06/09/2021 11:48:58 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1493 label Biography information for Sir Charles Walker

1281998

registered interest
date	29/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether a Band 4 Immuniser approved to administer the Pfizer vaccine has concurrent approval to administer the Astra-Zeneca vaccine; and if he will make a statement.
tabling member constituency	Broxbourne
tabling member printed	Sir Charles Walker
uin	145751
answer	answer is ministerial correction date of answer 03/02/2021 answer text <p>Public Health England has developed protocols in accordance with Regulation 247A of the Human Medicines Regulations 2012, inserted into Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020, for the administration of both the Pfizer BioNtech and AstraZeneca COVID-19 vaccines.</p><p> </p><p>The protocols do not specify which professional groups, grades or bands may administer COVID-19 vaccines under them. Instead, the protocols state that registered or non-registered persons may administer the vaccines, as long as they are competent to do so and experienced registered healthcare professionals must adequately supervise any non-professionally qualified persons.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 03/02/2021 13:50:44 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1493 label Biography information for Sir Charles Walker

1279640

registered interest
date	22/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that (a) elderly people and (b) people with underlying health conditions who are housebound receive the covid-19 vaccine in a timely manner within their home; and if he will make a statement.
tabling member constituency	Broxbourne
tabling member printed	Sir Charles Walker
uin	141940
answer	answer is ministerial correction date of answer 17/03/2021 answer text <p>Local vaccination services play a vital role in reaching those who may be elderly or housebound. These services mobilise general practice, working together in groups of Primary Care Networks plus large and small community pharmacy sites. These services provide the largest number of locations and are well placed to support our highest risk individuals, many of whom already have a trusted relationship with their local health services. They also coordinate and deliver vaccination to people who are unable to attend a vaccination site, including visiting care homes, the homes of housebound individuals and other settings such as residential facilities for people with learning disabilities or autism.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 17/03/2021 13:02:44 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 77871 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1493 label Biography information for Sir Charles Walker

1279187

registered interest
date	21/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether immunosuppressed people will receive the second dose of the covid-19 vaccine within the recommended three week period; and if he will make a statement.
tabling member constituency	Broxbourne
tabling member printed	Sir Charles Walker
uin	141412
answer	answer is ministerial correction date of answer 18/02/2021 answer text <p>The Joint Committee for Vaccination and Immunisation (JCVI) has recommended that as many people on the JCVI priority list as possible should be offered a first vaccine dose as the initial priority. The four United Kingdom Chief Medical Officers agree with the JCVI that at this stage of the pandemic prioritising the first doses of vaccine for as many people as possible on the priority list will protect the greatest number of at-risk people overall in the shortest possible time. This will have the greatest impact on reducing mortality, severe disease and hospitalisations and in protecting the National Health Service and equivalent health services.</p><p> </p><p>For both vaccines, data provided to the Medicines and Healthcare products and Regulatory Agency demonstrates that whilst efficacy is optimised when a second dose is administered, both offer considerable protection after a single dose, in the short term. For both vaccines the second dose completes the course and is likely to be important for longer term protection.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 18/02/2021 12:05:50 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 77403 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1493 label Biography information for Sir Charles Walker

1278251

registered interest
date	19/01/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what support the Government is providing to the development of nasal spray vaccines such as (a) the Open Orphan and Codagenix collaboration and (b) SaNOtize; and if he will make a statement.
tabling member constituency	Broxbourne
tabling member printed	Sir Charles Walker
uin	140000
answer	answer is ministerial correction date of answer 25/01/2021 answer text <p>There are over 300 COVID-19 vaccines in development around the world, in addition to the 7 vaccine candidates already secured for the UK. The Vaccine Taskforce is continuing to monitor vaccines in development globally.</p><p> </p><p>Innovate UK is funding a number of COVID-19 vaccine projects with the aim to identify vaccines with alternative mechanisms of action and delivery, improved utility in low and middle-income countries, and greater scalability for mass manufacture.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 140001 question first answered 25/01/2021 16:28:44 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1493 label Biography information for Sir Charles Walker

1278258

registered interest
date	19/01/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, if his Department will make an assessment of whether covid-19 vaccine nasal sprays would be easier to (a) store, (b) distribute and (c) administer compared to such needle-based vaccines; and in the event that such a nasal spray passes its trial stages, if the Government will support it going forward for regulatory approval for use in all four nations of the UK; and if he will make a statement.
tabling member constituency	Broxbourne
tabling member printed	Sir Charles Walker
uin	140001
answer	answer is ministerial correction date of answer 25/01/2021 answer text <p>There are over 300 COVID-19 vaccines in development around the world, in addition to the 7 vaccine candidates already secured for the UK. The Vaccine Taskforce is continuing to monitor vaccines in development globally.</p><p> </p><p>Innovate UK is funding a number of COVID-19 vaccine projects with the aim to identify vaccines with alternative mechanisms of action and delivery, improved utility in low and middle-income countries, and greater scalability for mass manufacture.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 140000 question first answered 25/01/2021 16:28:44 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1493 label Biography information for Sir Charles Walker

1275325

registered interest
date	11/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of prioritising (a) paramedics, (b) healthcare professionals and (c) other staff involved in the transporting of covid-19 patients across regions for covid-19 vaccination; and if he will make a statement.
tabling member constituency	Broxbourne
tabling member printed	Sir Charles Walker
uin	135861
answer	answer is ministerial correction date of answer 11/03/2021 answer text <p>All frontline healthcare staff who are eligible for seasonal influenza vaccination should be offered the vaccine in phase one of the COVID-19 vaccination programme, including paramedics, healthcare professionals and staff involved in the transporting of COVID-19 patients.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 11/03/2021 17:49:52 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 74053 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1493 label Biography information for Sir Charles Walker